ChemicalBook > CAS DataBase List > Difamilast

Difamilast

Product Name
Difamilast
CAS No.
937782-05-3
Chemical Name
Difamilast
Synonyms
OPA15406);Difamilast;Difa Misite;Difamilast (OPA-15406;Difamilast 937782-05-3;Difamilast, 10 mM in DMSO;N-((2-(4-(difluoromethoxy)-3-isopropoxyphenyl)oxazol-4-yl)methyl)-2-ethoxybenzamide;N-[[2-[4-(Difluoromethoxy)-3-(1-methylethoxy)phenyl]-4-oxazolyl]methyl]-2-ethoxybenzamide;N-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide;Benzamide, N-[[2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]-4-oxazolyl]methyl]-2-ethoxy-
CBNumber
CB64694667
Molecular Formula
C23H24F2N2O5
Formula Weight
446.44
MOL File
937782-05-3.mol
More
Less

Difamilast Property

Density 
1.223±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO : 100 mg/mL (223.99 mM; Need ultrasonic)
pka
13.12±0.46(Predicted)
form 
Solid
color 
White to off-white
InChI
InChI=1S/C23H24F2N2O5/c1-4-29-18-8-6-5-7-17(18)21(28)26-12-16-13-30-22(27-16)15-9-10-19(32-23(24)25)20(11-15)31-14(2)3/h5-11,13-14,23H,4,12H2,1-3H3,(H,26,28)
InChIKey
VFBILHPIHUPBPZ-UHFFFAOYSA-N
SMILES
C(NCC1=COC(C2=CC=C(OC(F)F)C(OC(C)C)=C2)=N1)(=O)C1=CC=CC=C1OCC
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-0039262
Product name
Difamilast
Purity
99.20%
Packaging
5mg
Price
$500
Updated
2021/12/16
ChemScene
Product number
CS-0039262
Product name
Difamilast
Purity
99.20%
Packaging
10mg
Price
$850
Updated
2021/12/16
ChemScene
Product number
CS-0039262
Product name
Difamilast
Purity
99.20%
Packaging
25mg
Price
$1800
Updated
2021/12/16
ChemScene
Product number
CS-0039262
Product name
Difamilast
Purity
99.20%
Packaging
50mg
Price
$3000
Updated
2021/12/16
ChemScene
Product number
CS-0039262
Product name
Difamilast
Purity
99.20%
Packaging
100mg
Price
$4600
Updated
2021/12/16
More
Less

Difamilast Chemical Properties,Usage,Production

Uses

Difamilast (OPA-15406) is a topical, selective and nonsteroidal phosphodiesterase-4 (PDE4) inhibitor with particularly efficient inhibition of subtype B (IC50=11.2 nM). Difamilast can be used for the research of mild to moderate atopic dermatitis (AD)[1][2][3].

brand name

Moizerto

Biological Activity

Difamilast is a novel atopic dermatitis drug candidate discovered by Otsuka that has phosphodiesterase 4 (PDE4) inhibitory activity. 

Mechanism of action

Difamilast works by inhibiting the activity of the PDE4 enzyme, thereby reducing the degradation of intracellular cyclic adenosine monophosphate (cAMP). cAMP is an intracellular signaling molecule that regulates a variety of cellular functions, including inhibiting inflammatory responses. By increasing cAMP levels, Difamilast helps reduce the production of inflammatory cytokines and relieves symptoms of atopic dermatitis.

Synthesis

The synthesis of difamilast (15) begins with the monobenzylated protocatechuic acid ethyl ester 15.1. Phenol 15.1 is first converted to the corresponding isopropyl ether and then debenzylated under palladium-catalyzed hydrogenation to produce the phenol intermediate 15.3. Difluoromethylation of 15.3 is accomplished by the addition of sodium chlorodifluoroacetate 15.4 at elevated temperature in the presence of potassium carbonate. The decarboxylation C-O bond formation reaction is likely to occur via a difluorocarbene process. The difluoromethylated product is treated with acid and then hydrolyzed in an alkaline medium to produce the benzoic acid derivative 15.5. The benzoic acid 15.5 is then converted to the benzamide 15.6 via the benzimide intermediate. The benzamide 15.6 is condensed with 1-ethoxy-3-chloroacetone 15.7 to produce the oxazole derivative, which is then saponified and recrystallized from 50% aqueous methanol to produce the alcohol 15.8.

Conversion of oxazole alcohol 15.8 to difamilast (15). First, alcohol 15.8 was converted to bromide 15.9 via an activation-displacement process, passing through a mesylate intermediate. Then, the alkyl bromide 15.9 was treated with potassium oxalimide to introduce the nitrogen center via an SN2-type displacement. Methylamine-mediated oxalimide deprotection and subsequent salt formation steps generated the amine 15.11 as a hydrochloride in a total yield of 69% over three steps. Finally, the hydrochloride 15.11 was treated with aqueous sodium carbonate to generate the free amine, which was subjected to an amide bond formation reaction with 2-ethoxybenzoic acid 15.12 and recrystallized from water and ethanol to give Difamilast (15).

in vitro

Difamilast has particularly efficient inhibition of subtype B (IC50=11.2 nM). It (OPA-15406) improves skin condition in relevant animal models of AD.

in vivo

Difamilast has particularly efficient inhibition of subtype B (IC50=11.2 nM). It (OPA-15406) improves skin condition in relevant animal models of AD.

in vivo

OPA-1540 improves skin condition in relevant animal models of AD[1].

IC 50

PDE4B: 11.2 nM (IC50)

References

[1] Hanifin JM, et, al. OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-con DOI:10.1016/j.jaad.2016.04.001
[2] Ahluwalia J, et, al. Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook. Drugs. 2017 Sep;77(13):1389-1397. DOI:10.1007/s40265-017-0784-3
[3] Soeberdt M, et, al. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis. Eur J Pharmacol. 2020 Aug 15;881:173242. DOI:10.1016/j.ejphar.2020.173242

Difamilast Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Difamilast Suppliers

Bayee Biotech (Anqing) Co., Ltd.
Tel
0556-5032306 18917961636
Email
wtx@bayeebio.com
Country
China
ProdList
239
Advantage
61
Hefei TianRui Pharmaceutical Chemistry Co., Ltd.
Tel
0551-68933033 13956024211
Fax
0551-68935833
Email
trchem@163.com
Country
China
ProdList
98
Advantage
58
Nanjing Chemlin Chemical Co., Ltd
Tel
025-83697070
Fax
+86-25-83453306
Email
info@chemlin.com.cn
Country
China
ProdList
16075
Advantage
64
Zhengzhou HSH Science & Technology Co., Ltd.
Tel
0371-55932928 18937192232
Fax
0086-0371-55932928
Email
1282296214@qq.com
Country
China
ProdList
498
Advantage
55
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Fax
+86-21-52996696
Country
China
ProdList
4769
Advantage
55
Nanjing ERan Biological Pharmaceutical Co., Ltd.
Tel
13770809694
Fax
+86 25 56203983
Email
googlexu_0114@sina.com
Country
China
ProdList
990
Advantage
58
Changzhou PBpharmaceutical R&D Co.,Ltd
Tel
086-0519-83990708 18915800124
Fax
0519-83990708
Email
info@pbpharm.com
Country
China
ProdList
487
Advantage
55
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Fax
21-5161 9052
Email
Sales@ATKchemical.com
Country
China
ProdList
9125
Advantage
58
Hubei widely chemical technology Co., Ltd.
Tel
027-59402396 13419635609
Fax
027-83989310
Email
13419635609@163.com
Country
China
ProdList
1991
Advantage
55
Wuhan Wsem Biological Co., Ltd.
Tel
027-83778876 13667159345
Fax
027-83778876
Email
13667159345@163.com
Country
China
ProdList
1997
Advantage
55
Nanjing FuRuisi Medical Technology Co., Ltd.
Tel
025-83221260
Fax
02583221260
Email
renqing401@163.com
Country
China
ProdList
267
Advantage
55
Wellman Pharmaceutical Group Limited
Tel
027-027-83778875 15807197853
Fax
027-83991220
Email
15807197853@163.com
Country
China
ProdList
3931
Advantage
58
Shanghai Yanze Chemical Co., Ltd.
Tel
021-021-13773155751 19975051755
Email
260924549@qq.com
Country
China
ProdList
10524
Advantage
58
Nanjing Becas pharmatech Ltd.
Tel
13912903754
Email
info@becaspharma.com
Country
China
ProdList
2763
Advantage
58
Hubei Yuanmeng Biotechnology Co., Ltd
Tel
027-68897569 18120462897
Fax
027-68897569
Email
fiona@yuanmengbio.com
Country
China
ProdList
4657
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-59102966 18717199209
Fax
027-59379337
Email
2853877583@qq.com
Country
China
ProdList
2715
Advantage
58
Bide Pharmatech Ltd.
Tel
400-1647117 13681763483
Email
product02@bidepharm.com
Country
China
ProdList
59936
Advantage
58
Hubei Weideli Chemical Reagent Co.,Ltd.
Tel
133-3998-5473 13339985473
Email
C13339985473@163.com
Country
China
ProdList
4991
Advantage
58
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Country
China
ProdList
24961
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-59105166; 13125137732
Email
2853863890@qq.com
Country
China
ProdList
2987
Advantage
58
Zhengzhou Converging Chemical Co. LTD
Tel
0371-53399770 18037166334
Email
2853031800@qq.com
Country
China
ProdList
5891
Advantage
58
Zibo Biopolar Rongchuang Pharmaceutical Co. Ltd.
Tel
0533-6092686 13371592196
Email
ddliu@bio-polar.cn
Country
China
ProdList
2229
Advantage
58
FarmaSino Pharmaceuticals (Jiangsu) Co.,Ltd
Tel
25-8690-7345 18651693585
Email
zfx@farmasino.com
Country
China
ProdList
136
Advantage
58
Shaanxi Xihua Chemical Industry Co., Ltd
Tel
029-029-81123119 17391733320
Email
1021@dideu.com
Country
China
ProdList
9995
Advantage
58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-025-66113011 18626450290
Email
cb5@aikonchem.com
Country
China
ProdList
10358
Advantage
58
https://hanhongsci.com/
Tel
021-54306202 18917919676
Email
info@hanhongsci.com
Country
China
ProdList
29995
Advantage
58
Nanjing Lebang Pharmaceutical Technology Co., Ltd
Tel
18860950986
Email
tangmanman@lebangpharma.com
Country
China
ProdList
650
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
025-85560043 15850508050
Fax
025-85563444
Email
cindy.huang@synzest.com
Country
China
ProdList
12000
Advantage
58
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Country
China
ProdList
9835
Advantage
58
Chengdu Peter-like Biotechnology Co., Ltd.
Tel
028-81700200 13308200041
Email
2851167782@qq.com
Country
China
ProdList
11146
Advantage
58
Sangon Biotech (Shanghai) Co.,Ltd.
Tel
400-821-026
Email
Sales@sangon.com
Country
China
ProdList
6710
Advantage
58
Nanjing Yikangda Pharmaceutical Technology Co.LTD
Tel
18118984557; 18118984557
Email
753016615@qq.com
Country
China
ProdList
472
Advantage
58
Cayman Chemical Company
Tel
800-364-9897
Email
sales@caymanchem.com
Country
China
ProdList
6838
Advantage
58
Hunan Zengda Biotechnology Co., Ltd
Tel
18274875143 18932421294
Email
18932421294@163.com
Country
China
ProdList
38
Advantage
58
Shanghai Yatan Pharmaceutical Research and Development Co. LTD
Tel
021-58003085 18817202306
Fax
QQ1060196522
Email
quhs@neutanpharma.com
Country
China
ProdList
182
Advantage
58
Zibo Hangyu Biotechnology Development Co., Ltd
Tel
+86-0533-2185556 +8615965530500
Email
nickzhang@hangyubiotech.com
Country
China
ProdList
8510
Advantage
58
Chongqing jooe co., ltd
Tel
+undefined86-15223382610
Email
info@jooe.com
Country
China
ProdList
6208
Advantage
58
Hefei TianRui Pharmaceutical Chemical Co., Ltd.
Tel
+86-0551-68665055 +86-+86-18616906106
Email
sales@trywchem.com
Country
China
ProdList
183
Advantage
58
Hangzhou MolCore BioPharmatech Co.,Ltd.
Tel
+86-057181025280; +8617767106207
Fax
0571-85806285
Email
sales@molcore.com
Country
China
ProdList
49734
Advantage
58
Jiangxi Huihe Chemical Co., Ltd.
Tel
+86-19189228086 +8618858568638
Email
wuzhouding@huihecrop.com
Country
China
ProdList
886
Advantage
58
Neobioscience Co., Ltd.
Tel
--
Fax
--
Email
info@neobioscience.com
Country
CHINA
ProdList
6207
Advantage
58
Guangzhou Bairui Medicine Co., Ltd.
Tel
--
Fax
--
Email
goldg@gzbr.com.cn
Country
China
ProdList
74
Advantage
38
Absin Bioscience Inc.
Tel
--
Fax
--
Email
chenjw@absin.cn
Country
CHINA
ProdList
6208
Advantage
58
Proteintech China
Tel
--
Fax
--
Email
Proteintech-CN@ptglab.com
Country
CHINA
ProdList
6290
Advantage
58

937782-05-3, DifamilastRelated Search:


  • Difamilast 937782-05-3
  • Difamilast (OPA-15406
  • OPA15406)
  • Benzamide, N-[[2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]-4-oxazolyl]methyl]-2-ethoxy-
  • N-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide
  • Difamilast,PDE4,OPA 15406,Inhibitor,atopic,phosphodiesterase-4,OPA15406,Phosphodiesterase (PDE),OPA-15406,dermatitis,subtype,inhibit
  • Difamilast
  • N-((2-(4-(difluoromethoxy)-3-isopropoxyphenyl)oxazol-4-yl)methyl)-2-ethoxybenzamide
  • Difamilast, 10 mM in DMSO
  • N-[[2-[4-(Difluoromethoxy)-3-(1-methylethoxy)phenyl]-4-oxazolyl]methyl]-2-ethoxybenzamide
  • Difa Misite
  • 937782-05-3
  • API